Ado-trastuzumab emtansine and Timolol eent

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: n.a.
• Other Brand Names: Kadcyla

Ado-trastuzumab emtansine is used to treat a HER2-positive breast cancer. ado-trastuzumab emtansine is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic).

Ado-trastuzumab emtansine is usually given after other treatments have failed.

Kadcyla (ado-trastuzumab) should not be used in place of Herceptin (trastuzumab).

Ado-trastuzumab emtansine may also be used for purposes not listed in this medication guide.

• Generic Name: timolol ophthalmic
• Dosage Forms: n.a.
• Other Brand Names: Betimol, Istalol, Timoptic Ocudose, Timoptic Ocumeter, Timoptic Ocumeter Plus, Timoptic-XE, Timoptic

Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension. Used alone or in conjunction with another IOP-lowering drug (e.g., latanoprost, a carbonic anhydrase inhibitor).

Fixed-combination preparation containing timolol maleate and dorzolamide hydrochloride used to reduce elevated IOP in patients with open-angle glaucoma or ocular hypertension who have not responded adequately (i.e., failed to achieve target IOP as determined after multiple measurements over time) to a topical β-adrenergic blocking agent.

Fixed-combination preparation associated with slightly smaller decrease in IOP than combination therapy with timolol (administered twice daily) and dorzolamide (administered 3 times daily).